Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Capmatinib

Various toxicities: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Illini O, et al. Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program. Therapeutic Advances in Medical Oncology 14: 13 Jun 2022. Available from: URL: http://doi.org/10.1177/17588359221103206 Illini O, et al. Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program. Therapeutic Advances in Medical Oncology 14: 13 Jun 2022. Available from: URL: http://​doi.​org/​10.​1177/​1758835922110320​6
Metadaten
Titel
Capmatinib
Various toxicities: 5 case reports
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41778-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Infliximab

Case report

Tisagenlecleucel